External Infusion Pumps
National · Effective Jan 25, 2026
1 active Medicare policy lists J7356, and 4 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
National · Effective Jan 25, 2026
4 policies from 4 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J7356 |
|---|---|---|
| Foscarbidopa with foslevodopa (e.g., Vyalev) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J7356 |
|---|---|---|
| Carbidopa-Levodopa ER Capsules (Crexont, Rytary), Enteral Suspension (Duopa), IR Tablets (Dhivy), Foscarbidopa/Foslevodopa (Vyalev); CP.PMN.238 | Not recorded | Covered with conditionsInferred from policy title |
| Policy | Effective | Status of J7356 |
|---|---|---|
| Advanced Parkinson’s disease infusions: foscarbidopa and foslevodopa (Vyalev), apomorphine Hcl (Onapgo) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J7356 |
|---|---|---|
| Vyalev (foscarbidopa/foslevodopa) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |